Autologous stem-cell transplantation may be safe without transfusion support – 2 Minute Medicine
2 Minute Medicine |
Autologous stem–cell transplantation may be safe without transfusion support
2 Minute Medicine 1. In a prospective cohort study of over 120 Jehovah’s Witnesses with lymphoma and multiple myeloma, high-dose chemotherapy (HDC), and autologous stem–cell transplantation (ASCT) without transfusion support was associated with relatively low mortality … |
|
Some stem cells heal differently, researchers said
The Augusta Chronicle Forget the traditional view that certain stem cells will heal by becoming replacement cells for damaged tissue. The real power of these cells comes from their ability to regulate the immune response and spark the body’s own regenerative machinery … |
|
Some stem cells heal differently, researchers said
The Augusta Chronicle Forget the traditional view that certain stem cells will heal by becoming replacement cells for damaged tissue. The real power of these cells comes from their ability to regulate the immune response and spark the body’s own regenerative machinery … |
|
Indian biotech firm Stempeutics Research gets China Patent for its novel stem …
Economic Times BENGALURU: Bengaluru-based Stempeutics Research has been granted a process patent for its stem–cell based drug Stempeucel by the State Intellectual Property Office of the People’s Republic of China. Stempeutics said it has become the first company in … |
|
Indian biotech firm Stempeutics Research gets China Patent for its novel stem …
Economic Times BENGALURU: Bengaluru-based Stempeutics Research has been granted a process patent for its stem–cell based drug Stempeucel by the State Intellectual Property Office of the People’s Republic of China. Stempeutics said it has become the first company in … |
|
Indian biotech firm Stempeutics Research gets China Patent for its novel stem …
Economic Times BENGALURU: Bengaluru-based Stempeutics Research has been granted a process patent for its stem–cell based drug Stempeucel by the State Intellectual Property Office of the People’s Republic of China. Stempeutics said it has become the first company in … |
|
Indian biotech firm Stempeutics Research gets China Patent for its novel stem …
Economic Times BENGALURU: Bengaluru-based Stempeutics Research has been granted a process patent for its stem–cell based drug Stempeucel by the State Intellectual Property Office of the People’s Republic of China. Stempeutics said it has become the first company in … |